NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

Brain Tumours A cost too much to bear?

Report of the All-Party Parliamentary Group on Brain Tumours
Inquiry into the economic and social impacts of brain tumours

This is not an official publication of the House of Commons or the House of Lords. It has not been approved by either House or its committees. All-Party Parliamentary Groups are informal groups of Members of both Houses with a common interest in particular issues. The views expressed in this report are those of the group. This report was compiled by the Brain Tumour Research charity which provides the Secretariat to the All-Party Parliamentary Group on Brain Tumours.

Session 3 – Tuesday 26th June 2018

• Dr Navid Malik Non-executive board director, Northwest Biotherapeutics Inc

• Erik Ramos Special Projects, Northwest Biotherapeutics Inc

The APPGBT received expert written evidence from the following:

• Macmillan Cancer Support • Cancer Research UK • CLIC Sargent • Teenage Cancer Trust • Headway—the brain injury association • Children’s Brain Tumour Research Centre University of Nottingham • The Christie Hospital NHS Foundation Trust and Salford Royal NHS Foundation Trust • Brain Tumour North West, Northwest Biotherapeutics Inc
• Dr Alasdair Rooney University of Edinburgh • Tom’s Trust

References

70. Background information on regulations in Japan and the USA provided by Northwest Biotherapeutics, Inc in both written and oral evidence.

https://www.braintumourresearch.org/docs/default-source/default-document-library/public-affairs-and-campaigning-documents/18-11-20-brain-tumours---a-cost-too-much-to-bear_final-report_low-res-singles.pdf?sfvrsn=24&utm_source=e-news&utm_medium=email&utm_campaign=inquiry_report